Screening and Staging

There is no protocol for the d? Tracking who? T? expos? s? asbestos. Tests of d? Tracking more t? T can? Diagnosis tre m? Soth? Liom that m? Conventional methods and am? Improve the survival of patients. The level of the ost? Opontine s? Could rique? Be useful in the d? Tracking people expos? Es? asbestos m? Soth? liom. The level of soluble mesothelin-prot? Ine is? Lev? E in the s? Rum about 75% of patients at diagnosis, and he? T? sugg? r? May he? be useful for the d? tracking [4]. M? Doctors have begun? ? Mesomark test the test that measures levels of soluble mesothelin li? s? of prot? ines (SMRP) lib? r? s per cell m? Soth? liom patients [5].

Staging
M? Soth? Liom is d? Criteria as Localis? E if the cancer is found only on the membrane surface o? it originates. It is class? advance? if it has spread? e beyond? the membrane surface? other parts of the body, such as the lymph nodes, lungs, chest wall, or abdominal organs.